Lsmotinib

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C19H19FN4O2S
Molecular Weight	386.443
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

NC(=O)NC1=C(SC(=C1)C#CC2=CC=CC(F)=C2)C(=O)N[C@H]3CCCNC3

InChI

InChIKey=ULVAGWVTXBTFRN-AWEZNQCLSA-N

InChI=1S/C19H19FN4O2S/c20-13-4-1-3-12(9-13)6-7-15-10-16(24-19(21)26)17(27-15)18(25)23-14-5-2-8-22-11-14/h1,3-4,9-10,14,22H,2,5,8,11H2,(H,23,25)(H3,21,24,26)/t14-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C19H19FN4O2S
Molecular Weight	386.443
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 00:15:31 GMT 2025` Edited by `admin` on `Wed Apr 02 00:15:31 GMT 2025`
Record UNII	U2UY9TBQ8Z
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PHI-101

Preferred Name

English

Lsmotinib

Official Name

English

2-THIOPHENECARBOXAMIDE, 3-((AMINOCARBONYL)AMINO)-5-(2-(3-FLUOROPHENYL)ETHYNYL)-N-(3S)-3-PIPERIDINYL-

Systematic Name

English

N-(2-(N-((3S)(3-PIPERIDYL))CARBAMOYL)-5-(2-(3-FLUOROPHENYL)ETHYNYL)(3-THIENYL))AMINAMIDE

Systematic Name

English

lasmotinib [INN]

Common Name

English

PHI101

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

681819